BioSpace News Archive

The growing number of cases for chronic diseases such as cardiovascular diseases, diabetes, and hypertension among others, worldwide is promoting the need for monitoring devices.

The isothermal nucleic acid amplification technology/INAAT market has been estimated to experience numerous growth opportunities in the following years.

iZafe Group AB presents, August 26, its report for the second quarter.

BioVaxys Technology Corp. is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement.

89bio, Inc. announced the presentation of data from ENTRIGUE, its Phase 2 proof-of-concept trial of pegozafermin in severe hypertriglyceridemia at the European Society of Cardiology Congress 2022.

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, will present preclinical data supporting its bifunctional approach to complement inhibition at the 2022 European Meeting on Complement in Human Disease (EMCHD) Conference.

Akeso, Inc. announced a review article featuring on Cadonilimab, a first-in-class PD-1/CTLA-4 bi-specific antibody developed by the company, was published in Drugs, a peer-reviewed medical journal specializing in pharmaceutics.

Technological advancements have touched the shores of almost all sectors around the world.

By Material Type, Nylon Normal Balloon Catheters Are Expected To Occupy Dominant Revenue Share Of 50% In The Market

Wilmington, Delaware, United States, Transparency Market Research Inc. - Biomimetic materials are synthetic materials that mimic natural materials or that follow a design motif derived from nature.